Latest News
A new Yale-led study found that administration of cognitive behavioral therapy after a course of esketamine treatment can be effective in preventing relapse in patients with major depression and suicidal ideation. Samuel Wilkinson, MD, is lead author of the study, published in The Journal of Clinical Psychiatry.
- May 04, 2026
Ebony Dix, MD, left, assistant professor of psychiatry, and Victoria (Tia) Kozar, MD, right, second-year resident in the Yale Psychiatry Residency Program, were recognized with awards at the annual meeting of the American Association for Geriatric Psychiatry.
- May 01, 2026Source: The New York Times
"When we’re younger, we’re still trying to find ourselves. That journey can mean exploring different identities and spending energy trying to convince everybody of the person we wish we were,” said Ebony Dix, MD, assistant professor of psychiatry, in an interview with The New York Times.
- March 09, 2026Source: NBC Connecticut (with Dr. Robert Ostroff)
“During the winter months, we’re robbed of exposure to sunlight. In order to have vitamin D metabolized, you need sunlight. So people have low vitamin D levels, which is linked to depression,” said Robert Ostroff, MD, co-medical director of Interventional Psychiatry Service at Yale New Haven Psychiatric Hospital and clinical professor of Psychiatry at Yale School of Medicine.
- February 10, 2026Source: Psychiatric Services
In this column, Marcus Hughes, MD, assistant professor of psychiatry, advises that, as psychedelic mental health treatments advance, balanced racial-ethnic patient representation in these studies is important to allow for appropriate generalization of these studies’ efficacy and safety data.
- January 08, 2026Source: WFSB-TV Channel 3
One week into the new year, thousands of people across the country are participating in “Dry January,” a challenge to cut out alcohol for the entire month. “It’s a way of resetting after holiday spirits get a little bit out of hand and people tend to overdrink and overeat,” said Robert Ostroff, MD, co-medical director of interventional psychiatry at Yale New Haven Psychiatric Hospital.
- December 18, 2025Source: BMJ Mental Health
Greg Rhee, PhD, associate professor adjunct in psychiatry, is first author of a paper in BMJ Mental Health that reviews the effects of electroconvulsive therapy on all-cause mortality and suicide deaths in severe unipolar or bipolar depression using longitudinal studies.
- October 10, 2025Source: WTNH-TV News 8
On World Mental Health Day on October 10, Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to WTNH-TV News 8 about mental health as the seasons change, and his work with ketamine for treatment-resistant depression.
- September 16, 2025Source: Newsweek
"The increase (in adults suffering from or being treated for depression) is alarming, and it is important that we keep an open mind and explore all possible causes," Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, told Newsweek in a recent interview.
- August 08, 2025
A mobile phone app designed to deliver suicide-specific therapy reduced suicidal behavior among high-risk psychiatric inpatients, according to a new study by scientists at Yale School of Medicine and The Ohio State University Wexner Medical Center and College of Medicine.